As the opioid crisis continues, research on measures taken to alleviate it is much needed. Such research is one component of the Division of Health Policy and Insurance Research (HPI) portfolio.
Hefei Wen leads the division’s research on the implications of opioid regulation. Dr. Wen's work has been among the first to examine the behavioral health implications of Medicaid expansions, marijuana liberalization policies, prescription drug monitoring programs, opioid prescribing limit laws, and buprenorphine waiver requirements, especially in the context of the U.S. opioid crisis.
The Harvard Medical School Department of Population Medicine announces a call for submissions for a $1000 prize for the best paper on a topic in Population Medicine written by an Harvard Medical School or Harvard School of Dental Medicine student. The deadline for submissions is February 16, 2024.